MS31.02 Clinical Implementation of BAP1 Inhibitors

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.204
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Arabidopsis BAP1 and BAP2 Genes Are General Inhibitors of Programmed Cell Death

Plant Physiology
Plant ScienceGeneticsPhysiology
2007English

Clinical Significance of Immunohistochemistry for Detection of BAP1 Mutations in Uveal Melanoma

Modern Pathology
Forensic MedicinePathology
2014English

Microbial Efflux Systems and Inhibitors: Approaches to Drug Discovery and the Challenge of Clinical Implementation

Open Microbiology Journal
ImmunologyMicrobiology
2013English

NeuCode Proteomics Reveals Bap1 Regulation of Metabolism

Cell Reports
BiochemistryGeneticsMolecular Biology
2016English

Comparison of HDAC Inhibitors in Clinical Development

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2013English

Germline BAP1 Mutations Predispose to Malignant Mesothelioma

Nature Genetics
Genetics
2011English

Loss of the Tumor Suppressor BAP1 Causes Myeloid Transformation

Science
MultidisciplinaryPhilosophy of ScienceHistory
2012English

Genetic Determinants of P2Y12 Inhibitors and Clinical Implications

Interventional Cardiology Clinics
Cardiovascular MedicineCardiology
2017English

Analysing the Function of BAP1 in Uveal Melanoma

Acta Ophthalmologica
MedicineOphthalmology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy